Results 21 to 30 of about 81,856 (291)

Psychoanalytic and psychodynamic therapies for depression. The evidence base. [PDF]

, 2008
David Taylor, a consultant psychotherapist at the Tavistock & Portman NHS Foundation Trust (120 Belsize Lane, London NW3 5BA, UK. Email: dtaylor@tavi-port.nhs.uk), is the clinical lead of the Tavistock Adult Depression Study (a randomised controlled ...
Beutel, Churchill, Coryell, Crits-Christoph, Davanloo, David Taylor, Freud, Freud, Goldberg, Goldberg, Hirschfeld, Klein, Lambert, Luborsky, Mueller, Paykel, Robins, Roth, Weissman   +18 more
core   +1 more source

Inter and intra-hemispheric structural imaging markers predict depression relapse after electroconvulsive therapy: a multisite study. [PDF]

, 2017
Relapse of depression following treatment is high. Biomarkers predictive of an individual's relapse risk could provide earlier opportunities for prevention.
Abbott, Christopher C, Espinoza, Randall T, Hellemann, Gerhard, Joshi, Shantanu H, Leaver, Amber M, Narr, Katherine L, Sui, Jing, Wade, Benjamin SC, Woods, Roger P   +8 more
core   +3 more sources

Dysfunctional Cortical Gradient Topography in Treatment-Resistant Major Depressive Disorder

Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 2023
Treatment-resistant depression (TRD) refers to patients with major depressive disorder who do not remit after 2 or more antidepressant trials. TRD is common and highly debilitating, but its neurobiological basis remains poorly understood. Recent neuroimaging studies have revealed cortical connectivity gradients that dissociate primary sensorimotor ...
Lorenzo Pasquini, Susanna L. Fryer, Stuart J. Eisendrath, Zindel V. Segal, Alex J. Lee, Jesse A. Brown, Manish Saggar, Daniel H. Mathalon   +7 more
openaire   +4 more sources

Clinical Guidelines of the Egyptian Psychiatric Association for the Management of Treatment-Resistant Unipolar Depression in Egypt

Frontiers in Psychiatry, 2022
BackgroundMajor depressive disorder (MDD) is a public health burden that creates a strain not only on individuals, but also on the economy. Treatment-resistant depression in the course of major depressive disorder represents a clinically challenging ...
Momtaz Abdel-Wahab, Tarek Okasha, Mostafa Shaheen, Mohamed Nasr, Tarek Molokheya, Abd ElNasser Omar, Menan A. Rabie, Victor Samy, Hany Hamed, Mohamed Ali   +9 more
doaj   +1 more source

Electroconvulsive therapy mediates neuroplasticity of white matter microstructure in major depression. [PDF]

, 2014
Whether plasticity of white matter (WM) microstructure relates to therapeutic response in major depressive disorder (MDD) remains uncertain. We examined diffusion tensor imaging (DTI) correlates of WM structural connectivity in patients receiving ...
Clark, K, Espinoza, RT, Joshi, SH, Leaver, AM, Lyden, H, Narr, KL, Pirnia, T, Woods, RP   +7 more
core   +1 more source

Rare Copy Number Variation in Treatment-Resistant Major Depressive Disorder [PDF]

Biological Psychiatry, 2014
While antidepressant treatment response appears to be partially heritable, no consistent genetic associations have been identified. Large, rare copy number variants (CNVs) play a role in other neuropsychiatric diseases, so we assessed their association with treatment-resistant depression (TRD).We analyzed data from two genome-wide association studies ...
Colm, O'Dushlaine, Stephan, Ripke, Douglas M, Ruderfer, Steven P, Hamilton, Maurizio, Fava, Dan V, Iosifescu, Isaac S, Kohane, Susanne E, Churchill, Victor M, Castro, Caitlin C, Clements, Sarah R, Blumenthal, Shawn N, Murphy, Jordan W, Smoller, Roy H, Perlis   +13 more
openaire   +2 more sources

Lifetime Bipolar Disorder comorbidity and related clinical characteristics in patients with primary Obsessive Compulsive Disorder: a report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS) [PDF]

, 2019
IntroductionBipolar disorder (BD) and obsessive compulsive disorder (OCD) are prevalent, comorbid, and disabling conditions, often characterized by early onset and chronic course.
Benatti, Beatrice, Cirnigliaro, Giovanna, Dell'Osso, Bernado, Fineberg, Naomi, Grancini, Benedetta, Grassi, Giacomo, Hollander, Eric, Hranov, Georgi, Hranov, Luchezar, Karamustafalioglu, Oguz, Lanzagorta, Nuria, Lochner, Christine, Marazziti, Donatella, Menchon, Josè M, Nicolini, Humberto, Pallanti, Stefano, Rodriguez, Carolyn I, Stein, Dan J., Van Ameringen, Michael, Vismara, Matteo, Zohar, Joseph   +20 more
core   +4 more sources

All-cause mortality in patients with treatment-resistant depression: a cohort study in the US population

Annals of General Psychiatry, 2019
Background Treatment-resistant depression (TRD) may represent a substantial proportion of major depressive disorder (MDD); however, the risk of mortality in TRD is still incompletely assessed. Methods Data were obtained from Optum Clinformatics™ Extended,
Gang Li, Daniel Fife, Grace Wang, John J. Sheehan, Robert Bodén, Lena Brandt, Philip Brenner, Johan Reutfors, Allitia DiBernardo   +8 more
doaj   +1 more source

Overcoming the myths of esketamine administration: different and not difficult

Frontiers in Psychiatry, 2023
Intranasal esketamine for treatment-resistant depression has been introduced and approved by the FDA and EMA in 2019 and 2020, respectively. Since then, the administration practices were found different among countries. Major depression has a high impact
Florian Buchmayer, Siegfried Kasper
doaj   +1 more source

A Southeast Asia Consensus on the Definition and Management of Treatment-Resistant Depression

Neuropsychiatric Disease and Treatment, 2022
Phern Chern Tor,1 Nurmiati Amir,2 Johnson Fam,3 Roger Ho,3 Pichai Ittasakul,4 Margarita M Maramis,5 Benita Ponio,6 Dharmawan Ardi Purnama,7 Wanida Rattanasumawong,8 Elizabeth Rondain,9 Ahmad Hatim Bin Sulaiman,10 Kannokarn Wiroteurairuang,11 Kok Yoon ...
Tor PC, Amir N, Fam J, Ho R, Ittasakul P, Maramis MM, Ponio B, Purnama DA, Rattanasumawong W, Rondain E, Bin Sulaiman AH, Wiroteurairuang K, Chee KY   +12 more
doaj